Published human trials mainly studied oral and intravenous forms, so subcutaneous amounts come from community practice rather than an approved clinical protocol
Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved
To start, drugmakers are experimenting with dosage
BPC-157 has many functions, such as attenuating liver, Citation10 lung, Citation11 colon, Citation12 and gastric lesions, Citation13 displaying antianxiety and antidepressant effects, Citation14 improving angiogenesis and wound healing, Citation15 reversing 1-methyl-4-phenvl-1,2,3,6-tetrahvdropvridine (MPTP)-specific motor abnormalities in Parkinsons disease models, Citation16 having mucosal protective and anti-inflammatory effects, Citation17 particularly those affecting the dopamine system, Citation18 and persistent activity